Difficulty: Medium
Average Score: 93%
Practice
Patient with diabetes has hyperlipidemia. Which drug of the following cannot be used in his case due to the risk of development of hyperglycemia?
Correct answer
A
Rationale
A' is correct because niacin increases hyperglycemia risk by worsening insulin resistance, contraindicated in diabetes, per endocrinology. 'B' (statins), 'C' (colestipol), and 'D' (ezetimibe) are safer, with minimal glucose effects. Niacin's metabolic impact limits its use here.